In some cases, dosing far exceeds anything studied in clinical trials
The catch is that human efficacy data is essentially absent, and long-term safety in people is unknown
This predictable pharmacokinetic profile allows for consistent, daily dosing without the risk of dangerous buildup
70 HP 130 BPC-157 Pentadecapeptide Cytoprotection ALIASES BPC157, Body Protection Compound 157, PL 14736, pentadecapeptide CLASS Synthetic 15-amino-acid peptide gastric-origin fragment FORMULA C62H98N16O22 SEQUENCE Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val HALF-LIFE ~4 hours (rat, intraperitoneal) ROUTES Subcutaneous Intraperitoneal Oral (animal studies) MECHANISM OF ACTION Synthetic 15-amino-acid fragment of a gastric protective protein
How does this peptide blend differ from buying BPC-157 and TB-500 separately
Observers have been wildly ruminating on the various implications of the U.S.-Iran cease-fire agreement, the so-called Islamabad Memorandum of Understanding
